We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA OK of Follow-On Osteoarthritis Drug Deepens Nuvo, Mallinckrodt Scrap
FDA OK of Follow-On Osteoarthritis Drug Deepens Nuvo, Mallinckrodt Scrap
The FDA has approved a new formulation of Nuvo Research and Mallinckrodt’s osteoarthritis drug Pennsaid for the treatment of osteoarthritis knee pain, but not the broader indication of signs and symptoms of the disease — adding a new wrinkle to the fight between the two partner companies co-developing the drug.